Allergan plc

Clonshaugh Business and Technology Park
Coolock, Dublin
D17 E400

Allergan plc articles

Displaying 1 - 1 of 1

TrueTear granted marketing authorisation by the FDA

TrueTear granted marketing authorisation by the FDA
Allergan plc has announced that it has been granted marketing authorisation from the U.S. FDA for TrueTear Intranasal Tear Neurostimulator, the first and only FDA-cleared device developed to temporarily increase tear production during neurostimulation in adult patients. TrueTear is a handheld stimulator with daily disposable tips that is inserted into the nasal cavity to induce the production of tears.
26th April 2017

Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

CES 2018
9th January 2018
United States of America Las Vegas, Nevada
Developing wearable products: technology and opportunities
17th January 2018
United Kingdom Cocoon Networks, London
Smart Mobility Executive Forum
12th February 2018
Germany Berlin
embedded world 2018
27th February 2018
Germany Nuremberg
Industry 4.0 Summit 2018
28th February 2018
United Kingdom Manchester